Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
PTGX Price/Volume Stats
| Current price | $53.82 | 52-week high | $60.60 |
| Prev. close | $51.53 | 52-week low | $30.67 |
| Day low | $50.60 | Volume | 947,300 |
| Day high | $53.97 | Avg. volume | 1,003,289 |
| 50-day MA | $45.85 | Dividend yield | N/A |
| 200-day MA | $43.58 | Market Cap | 3.34B |
PTGX Stock Price Chart Interactive Chart >
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
PTGX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PTGX Price Returns
| 1-mo | 24.90% |
| 3-mo | 40.34% |
| 6-mo | 27.96% |
| 1-year | 58.20% |
| 3-year | 484.36% |
| 5-year | 235.33% |
| YTD | 39.43% |
| 2024 | 68.34% |
| 2023 | 110.17% |
| 2022 | -68.10% |
| 2021 | 69.64% |
| 2020 | 185.96% |